These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35952818)

  • 1. Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein.
    Chakraborty C; Bhattacharya M; Sharma AR; Mallik B
    Int J Biol Macromol; 2022 Oct; 219():980-997. PubMed ID: 35952818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions.
    Bhattacharya M; Sharma AR; Dhama K; Agoramoorthy G; Chakraborty C
    Geroscience; 2022 Apr; 44(2):619-637. PubMed ID: 35258772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs.
    Chakraborty C; Bhattacharya M; Sharma AR; Dhama K; Agoramoorthy G
    Geroscience; 2022 Oct; 44(5):2393-2425. PubMed ID: 35989365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant.
    Jawad B; Adhikari P; Podgornik R; Ching WY
    J Phys Chem Lett; 2022 May; 13(17):3915-3921. PubMed ID: 35481766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain.
    Pitsillou E; Liang JJ; Beh RC; Hung A; Karagiannis TC
    Comput Biol Med; 2022 Oct; 149():106035. PubMed ID: 36055162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
    Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
    J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations.
    Verkhivker G; Agajanian S; Kassab R; Krishnan K
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
    Kumar S; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rapid emergence of multiple sublineages of Omicron (B.1.1.529) variant: Dynamic profiling via molecular phylogenetics and mutational landscape studies.
    Chakraborty C; Bhattacharya M; Sharma AR; Dhama K; Lee SS
    J Infect Public Health; 2022 Nov; 15(11):1234-1258. PubMed ID: 36270226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of the tight binding mode to ACE2 triggered by multi-point mutations in the omicron variant: a dynamic insight.
    Zhao X; Xiong D; Luo S; Duan L
    Phys Chem Chem Phys; 2022 Apr; 24(15):8724-8737. PubMed ID: 35373810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant.
    Zhang W; Shi K; Geng Q; Ye G; Aihara H; Li F
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2206509119. PubMed ID: 36256797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
    Almalki SSR; Izhari MA; Alyahyawi HE; Alatawi SK; Klufah F; Ahmed WAM; Alharbi R
    J Multidiscip Healthc; 2023; 16():2117-2136. PubMed ID: 37529147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant.
    Wang WB; Ma YB; Lei ZH; Zhang XF; Li J; Li SS; Dong ZY; Liang Y; Li QM; Su JG
    J Mol Graph Model; 2023 Nov; 124():108540. PubMed ID: 37352723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis.
    Kumar R; Srivastava Y; Muthuramalingam P; Singh SK; Verma G; Tiwari S; Tandel N; Beura SK; Panigrahi AR; Maji S; Sharma P; Rai PK; Prajapati DK; Shin H; Tyagi RK
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of human ACE2 and RBD of Omicron enhanced by unique interaction patterns among SARS-CoV-2 variants of concern.
    Kim S; Liu Y; Ziarnik M; Seo S; Cao Y; Zhang XF; Im W
    J Comput Chem; 2023 Feb; 44(4):594-601. PubMed ID: 36398990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 in relation to global vaccination and booster doses: what is the future of vaccination in the battle against COVID-19?
    Khalid N; Wheeler AM
    Bratisl Lek Listy; 2022; 123(9):631-633. PubMed ID: 36039880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants.
    Chakraborty S; Saha A; Saha C; Ghosh S; Mondal T
    Biochem Biophys Res Commun; 2022 Oct; 627():168-175. PubMed ID: 36041326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
    Alkhatib M; Salpini R; Carioti L; Ambrosio FA; D'Anna S; Duca L; Costa G; Bellocchi MC; Piermatteo L; Artese A; Santoro MM; Alcaro S; Svicher V; Ceccherini-Silberstein F
    Microbiol Spectr; 2022 Apr; 10(2):e0273221. PubMed ID: 35352942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.